Apollomics Inc Cl A
(APLM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLM | NEUP | LIXT | ||
| Company | Apollomics Inc Cl A | Neuphoria Therapeutics Inc | Lixte Biotech Hlds | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 19.07 | 3.96 | 2.78 | ||
| High | 21.24 | 4.01 | 3.09 | ||
| Low | 18.78 | 3.94 | 2.45 | ||
| Latest | 19.99 | 4.01 | 3.06 | ||
| Change | +1.34 | -0.04 | +0.37 | ||
| % Change | +7.18% | -0.99% | +13.75% | ||
| Volume | 29,500 | 20,500 | 134,100 | ||
| 20-Day Average Volume | 14,945 | 32,420 | 106,570 | ||
| Previous Close | 18.65 | 4.05 | 2.69 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 19.29 | 4.05 | 3.31 | ||
| 20-Day Raw Stochastic | 58.12% | 22.58% | 39.10% | ||
| 20-Day Relative Strength | 52.94 | 43.15 | 42.25 | ||
| Weighted Alpha | +11.74 | -21.66 | -45.61 | ||
| Today's Opinion | 100% Buy | 88% Sell | 72% Sell | ||
| Previous Opinion | 88% Buy | 80% Sell | 72% Sell | ||
| Last Month's Opinion | 100% Buy | 72% Sell | 24% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.62% since 02/04/26 | +0.25% since 02/04/26 | -4.97% since 02/04/26 | ||
| Low | 17.26 on 02/05/26 | 3.94 on 02/11/26 | 2.45 on 02/11/26 | ||
| High | 21.24 on 02/11/26 | 4.11 on 02/09/26 | 3.27 on 02/05/26 | ||
| 1-Month | |||||
| %Chg | -9.01% since 01/09/26 | -4.30% since 01/09/26 | -16.16% since 01/09/26 | ||
| Low | 17.20 on 02/02/26 | 3.94 on 02/11/26 | 2.45 on 02/11/26 | ||
| High | 22.80 on 01/13/26 | 4.29 on 01/12/26 | 4.01 on 01/29/26 | ||
| 3-Month | |||||
| %Chg | +30.57% since 11/11/25 | -18.00% since 11/11/25 | -30.61% since 11/11/25 | ||
| Low | 13.00 on 12/02/25 | 3.64 on 12/29/25 | 2.45 on 02/11/26 | ||
| High | 26.95 on 11/17/25 | 5.09 on 11/12/25 | 4.97 on 11/13/25 | ||
| 6-Month | |||||
| %Chg | +251.32% since 08/11/25 | -44.31% since 08/11/25 | -38.55% since 08/11/25 | ||
| Low | 3.66 on 08/29/25 | 3.64 on 12/29/25 | 2.45 on 02/11/26 | ||
| High | 42.12 on 10/15/25 | 21.40 on 10/07/25 | 6.26 on 09/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 20,576 | 21,778 | 20,112 | ||
| Shares Outstanding, K | 1,103 | 5,377 | 7,477 | ||
| Annual Sales | 1,490,000 | 15,650,000 | 0 | ||
| Annual Net Income | -53,860,000 | -370,000 | -3,590,000 | ||
| Last Quarter Sales | N/A | -10,000 | 0 | ||
| Last Quarter Net Income | N/A | -8,880,000 | -1,980,000 | ||
| 60-Month Beta | 1.78 | 0.52 | 0.93 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | -4.41 on 11/14/25 | -0.33 on 11/12/25 | ||
| Latest Earnings Date | 04/02/26 | 02/13/26 | 03/23/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||